These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30286230)

  • 1. Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Panwar A; Rieke K; Burke WJ; Sayles H; Lydiatt WM;
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1004-1010. PubMed ID: 30286230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-Novo Depression, Prophylactic Antidepressant, and Survival in Patients With Head and Neck Cancer.
    Panwar A; McGill T; Lydiatt D; Militsakh O; Lindau R; Coughlin A; Sayles H; Smith R; Lydiatt W
    Laryngoscope; 2023 Apr; 133(4):856-862. PubMed ID: 35730719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.
    Lydiatt WM; Bessette D; Schmid KK; Sayles H; Burke WJ
    JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):678-86. PubMed ID: 23788218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life and Depression Symptoms After Therapy De-Escalation in HPV+ Oropharyngeal Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
    Panwar A; Shah S; Reid AE; Lydiatt W; Holcomb AJ; Osmolak A; Coughlin A; Militsakh O; Su YB; Mirmiran A; Huang TS; Nolan N; Duckert R; Barney C; Chiu M; Nguyen C; Sayles H; Ganti AK; Lindau R
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):429-435. PubMed ID: 38573597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer.
    Lydiatt WM; Denman D; McNeilly DP; Puumula SE; Burke WJ
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):528-35. PubMed ID: 18490576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study.
    Barber B; Dergousoff J; Nesbitt M; Mitchell N; Harris J; O'Connell D; Côté D; Biron V; Seikaly H
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):38. PubMed ID: 26385356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.
    Klein MB; Lee T; Brouillette MJ; Sheehan NL; Walmsley S; Wong DK; Conway B; Hull M; Cooper C; Haidar S; Vezina S; Annable L; Young S; Zubyk W; Singer J
    HIV Clin Trials; 2014; 15(4):161-75. PubMed ID: 25143025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Risk For Depression and Quality of Life in Patients With Head and Neck Cancer.
    Henry M; Chen LM; Ducharme L; Devault-Tousignant C; Rosberger Z; Frenkiel S; Hier M; Zeitouni A; Kost K; Mlynarek A; Richardson K; Chartier G; Mascarella M; Sadeghi N; Sultanem K; Shenouda G; Cury FL; Meaney M
    JAMA Otolaryngol Head Neck Surg; 2024 Jul; 150(7):598-606. PubMed ID: 38814668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer.
    Zhang H; Xie M; Archibald SD; Jackson BS; Gupta MK
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1017-1022. PubMed ID: 30073295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
    Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
    Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized controlled trial of a brief early intervention for reducing posttraumatic stress disorder, anxiety and depressive symptoms in newly diagnosed head and neck cancer patients.
    Kangas M; Milross C; Taylor A; Bryant RA
    Psychooncology; 2013 Jul; 22(7):1665-73. PubMed ID: 23042612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser acupuncture for depression: a randomised double blind controlled trial using low intensity laser intervention.
    Quah-Smith I; Smith C; Crawford JD; Russell J
    J Affect Disord; 2013 Jun; 148(2-3):179-87. PubMed ID: 23337655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?
    Ma XR; Hou CL; Zang Y; Jia FJ; Lin YQ; Li Y; Chiu HF; Ungvari GS; Correll CU; Lai KY; Zhong BL; Cao XL; Cai MY; Yun J; Xiang YT
    J Affect Disord; 2015 Feb; 172():191-4. PubMed ID: 25451417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.